telmisartan has been researched along with Diabetes Mellitus, Type 1 in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frimodt-Møller, M; Hansen, CS; Hansen, TW; Heerspink, HJL; Jongs, N; Kooy, A; Kroonen, MYAM; Laursen, JC; Laverman, GD; Persson, F; Rossing, P; Rotbain Curovic, V; Zobel, EH | 1 |
| Eugen-Olsen, J; Hansen, TW; Heerspink, HJL; Houlind, MB; Jongs, N; Kooy, A; Kroonen, MYAM; Laverman, GD; Persson, F; Rossing, P; Rotbain Curovic, V; Tavenier, J; Zobel, EH | 1 |
| Sharma, K; Sweiss, N | 1 |
| Chang Li, J; Du, GT; Hong, H; Hu, M; Liu, GJ; Long, Y; Mei, ZL; Miao, MX; Wang, C | 1 |
| Chang, WT; Chen, ZC; Cheng, JT | 1 |
| Gaikwad, AB; Mulay, SR; Tikoo, K | 1 |
| Anantharaman, R; Bhadada, SK; Bhansali, A; Dutta, P; Jayaprakash, P; Kohli, HS; Upreti, V; Walia, R | 1 |
| Anantharaman, R; Bhadada, SK; Bhansali, A; Jayaprakash, P; Kohli, HS; Shanmugasundar, G; Walia, R | 1 |
| Zidek, W | 1 |
| Ceriello, A; Esposito, K; Giugliano, D; Piconi, L | 1 |
1 review(s) available for telmisartan and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Adiponectin effects on the kidney.
Topics: Adiponectin; Albuminuria; Amlodipine; AMP-Activated Protein Kinases; Animals; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Disease Progression; Humans; Kidney; Kidney Diseases; Mice; Obesity; Oxidative Stress; Perindopril; Renal Insufficiency, Chronic; Telmisartan | 2014 |
3 trial(s) available for telmisartan and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Effects of baricitinib, empagliflozin, linagliptin and telmisartan on cardiovascular autonomic neuropathy in type 1 diabetes: An exploratory, randomized, open-label, crossover trial.
Topics: Benzhydryl Compounds; Cross-Over Studies; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Humans; Hypoglycemic Agents; Linagliptin; Telmisartan | 2023 |
Overall and inter-individual effect of four different drug classes on soluble urokinase plasminogen activator receptor in type 1 and type 2 diabetes.
Topics: Adult; Biomarkers; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Linagliptin; Receptors, Urokinase Plasminogen Activator; Telmisartan | 2023 |
Telmisartan improves cardiac fibrosis in diabetes through peroxisome proliferator activated receptor δ (PPARδ): from bedside to bench.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Cell Line; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Cardiomyopathies; Female; Fibrosis; Humans; Longitudinal Studies; Male; Middle Aged; Myocardium; Myocytes, Cardiac; PPAR gamma; Prospective Studies; Rats, Sprague-Dawley; Signal Transduction; STAT3 Transcription Factor; Streptozocin; Telmisartan; Time Factors; Translational Research, Biomedical; Treatment Outcome; Up-Regulation; Ventricular Function, Left; Ventricular Remodeling | 2016 |
6 other study(ies) available for telmisartan and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Telmisartan treatment ameliorates memory deficits in streptozotocin-induced diabetic mice via attenuating cerebral amyloidosis.
Topics: Administration, Oral; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Angiotensin II Type 1 Receptor Blockers; Animals; Aspartic Acid Endopeptidases; Benzimidazoles; Benzoates; Cerebral Amyloid Angiopathy; Cerebral Cortex; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Hippocampus; Male; Memory Disorders; Mice; Mice, Inbred ICR; Peptide Fragments; Receptor for Advanced Glycation End Products; Streptozocin; Telmisartan; Transcription Factor RelA; Treatment Outcome | 2014 |
Combination of aspirin with telmisartan suppresses the augmented TGFbeta/smad signaling during the development of streptozotocin-induced type I diabetic nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Benzimidazoles; Benzoates; Cyclooxygenase 2; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Gene Expression Regulation; Inflammation; Male; NF-kappa B; Oxidative Stress; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad Proteins; Streptozocin; Telmisartan; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2010 |
Anti-albuminuric efficacy of a combination of angiotensin converting enzyme inhibitor & angiotensin receptor blocker in type 1 DM with nephropathy.
Topics: Albumins; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Combinations; Female; Humans; Male; Potassium; Ramipril; Statistics, Nonparametric; Telmisartan | 2010 |
A pilot study on the effect of telmisartan & ramipril on 24 h blood pressure profile & dipping pattern in type 1 diabetes patients with nephropathy.
Topics: Adult; Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pilot Projects; Ramipril; Telmisartan | 2011 |
[Diabetes and Nephropathy: ACE inhibitor for type 1, AT1 blocker for type 2].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enalapril; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Long-Term Care; Renal Dialysis; Telmisartan; Treatment Outcome | 2004 |
Telmisartan shows an equivalent effect of vitamin C in further improving endothelial dysfunction after glycemia normalization in type 1 diabetes.
Topics: Angiotensin II Type 1 Receptor Blockers; Antioxidants; Ascorbic Acid; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 1; Endothelium, Vascular; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Oxidative Stress; Telmisartan; Vascular Diseases | 2007 |